Imetelstat

Scientific Overview: Telomerase inhibitor; FDA approved 2024 for MDS (low-risk, transfusion-dependent). First telomerase inhibitor approved — new MDS mechanism

Mechanism of Action: Telomerase Inhibitor

Purity: ≥99%  |  Molecular Formula: Oligonucleotide

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.